NACDS Praises New Congressional Investigation of PBMs
U.S. House Oversight and Accountability Committee expands bipartisan Congressional push to stop pharmaceutical benefit manipulation by...
NACDS Praises New Congressional Investigation of PBMs
APhA releases survey results quantifying the impact of PBMs
Pharmacy Benefit Managers Put in Crosshairs of Drug Price Fight
Private Health Care Companies Are Eating the American Economy
Workplace health plans pay up to 30 times more than Medicare for specialty drugs
Senate bill aims to crack down on how drug company ‘middlemen’ negotiate prices
Patients needing home IV nutrition fear dangerous shortages
Oklahoma Pharmacy Board unanimously approves new rules for shipping mail-order medications
A decade-long battle over Medicare Advantage audits is coming to a head
It is Time for Policymakers to Protect Patients from Predatory Practices of Insurers and PBMs
FTC action on PBMs could be just what the doctor ordered to improve patient outcomes
Drug Pricing Oversight to Get Prime Focus Under New Congress
Will your insurance company cover the copay for a costly drug?
Lawsuit filed against national insulin manufacturers by Kansas Attorney General
The next drug pricing battle: PBMs
Inequity in Pharmacy Benefit Managers’ Drug Pricing Practices in Oregon Raises Serious Questions
AARP: An Organization that Stands with PBM Kickbacks and Hidden Prices
Consumers Overpay for Generic Alternatives, Study Results Show
In Memoriam: Morris Gortler
CVC to CMS: Ongoing Cuts Undermine Healthcare Access and Quality Care